File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus

TitleCore outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus
Authors
Issue Date2021
PublisherOxford University Press: Policy B. The Journal's web site is located at https://academic.oup.com/bjs
Citation
British Journal of Surgery, 2021, v. 108 n. 10, p. 1216-1224 How to Cite?
AbstractBackground: Surgery is the primary treatment that can offer potential cure for gastric cancer, but is associated with significant risks. Identifying optimal surgical approaches should be based on comparing outcomes from well designed trials. Currently, trials report different outcomes, making synthesis of evidence difficult. To address this, the aim of this study was to develop a core outcome set (COS)—a standardized group of outcomes important to key international stakeholders—that should be reported by future trials in this field. Methods: Stage 1 of the study involved identifying potentially important outcomes from previous trials and a series of patient interviews. Stage 2 involved patients and healthcare professionals prioritizing outcomes using a multilanguage international Delphi survey that informed an international consensus meeting at which the COS was finalized. Results: Some 498 outcomes were identified from previously reported trials and patient interviews, and rationalized into 56 items presented in the Delphi survey. A total of 952 patients, surgeons, and nurses enrolled in round 1 of the survey, and 662 (70 per cent) completed round 2. Following the consensus meeting, eight outcomes were included in the COS: disease-free survival, disease-specific survival, surgery-related death, recurrence, completeness of tumour removal, overall quality of life, nutritional effects, and ‘serious’ adverse events. Conclusion: A COS for surgical trials in gastric cancer has been developed with international patients and healthcare professionals. This is a minimum set of outcomes that is recommended to be used in all future trials in this field to improve trial design and synthesis of evidence.
Persistent Identifierhttp://hdl.handle.net/10722/305906
ISSN
2021 Impact Factor: 11.122
2020 SCImago Journal Rankings: 2.202
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorAlkhaffaf, B-
dc.contributor.authorMetryka, A-
dc.contributor.authorBlazeby, JM-
dc.contributor.authorGlenny, AM-
dc.contributor.authorAdeyeye, A-
dc.contributor.authorCosta, PM-
dc.contributor.authorDiez Del Val, I-
dc.contributor.authorGisbertz, SS-
dc.contributor.authorGuner, A-
dc.contributor.authorLaw, S-
dc.contributor.authorLee, HJ-
dc.contributor.authorLi, Z-
dc.contributor.authorNakada, K-
dc.contributor.authorReim, D-
dc.contributor.authorVorwald, P-
dc.contributor.authorBaiocchi, GL-
dc.contributor.authorAllum, W-
dc.contributor.authorChaudry, MA-
dc.contributor.authorGriffiths, EA-
dc.contributor.authorWilliamson, PR-
dc.contributor.authorBruce, IA-
dc.date.accessioned2021-10-20T10:16:01Z-
dc.date.available2021-10-20T10:16:01Z-
dc.date.issued2021-
dc.identifier.citationBritish Journal of Surgery, 2021, v. 108 n. 10, p. 1216-1224-
dc.identifier.issn0007-1323-
dc.identifier.urihttp://hdl.handle.net/10722/305906-
dc.description.abstractBackground: Surgery is the primary treatment that can offer potential cure for gastric cancer, but is associated with significant risks. Identifying optimal surgical approaches should be based on comparing outcomes from well designed trials. Currently, trials report different outcomes, making synthesis of evidence difficult. To address this, the aim of this study was to develop a core outcome set (COS)—a standardized group of outcomes important to key international stakeholders—that should be reported by future trials in this field. Methods: Stage 1 of the study involved identifying potentially important outcomes from previous trials and a series of patient interviews. Stage 2 involved patients and healthcare professionals prioritizing outcomes using a multilanguage international Delphi survey that informed an international consensus meeting at which the COS was finalized. Results: Some 498 outcomes were identified from previously reported trials and patient interviews, and rationalized into 56 items presented in the Delphi survey. A total of 952 patients, surgeons, and nurses enrolled in round 1 of the survey, and 662 (70 per cent) completed round 2. Following the consensus meeting, eight outcomes were included in the COS: disease-free survival, disease-specific survival, surgery-related death, recurrence, completeness of tumour removal, overall quality of life, nutritional effects, and ‘serious’ adverse events. Conclusion: A COS for surgical trials in gastric cancer has been developed with international patients and healthcare professionals. This is a minimum set of outcomes that is recommended to be used in all future trials in this field to improve trial design and synthesis of evidence.-
dc.languageeng-
dc.publisherOxford University Press: Policy B. The Journal's web site is located at https://academic.oup.com/bjs-
dc.relation.ispartofBritish Journal of Surgery-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleCore outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus-
dc.typeArticle-
dc.identifier.emailLaw, S: slaw@hku.hk-
dc.identifier.authorityLaw, S=rp00437-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1093/bjs/znab192-
dc.identifier.pmid34165555-
dc.identifier.hkuros328093-
dc.identifier.volume108-
dc.identifier.issue10-
dc.identifier.spage1216-
dc.identifier.epage1224-
dc.identifier.isiWOS:000715383200039-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats